Nelson, Adam
McMullen, Nichole
Gebremeskel, Simon
De Antueno, Roberto
Mackenzie, Duncan
Duncan, Roy
Johnston, Brent
Funding for this research was provided by:
Canadian Institutes of Health Research (FDN-143305, PJT-153285)
Canadian Cancer Society (705457)
Article History
Received: 6 December 2023
Accepted: 30 March 2024
First Online: 15 May 2024
Declarations
:
: All experimental procedures were approved by the University Committee on Laboratory Animals following the guidelines of the Canadian Council on Animal Care.
: Not applicable.
: R.D. is a minority shareholder and board member of Entos Pharmaceuticals. The authors have no additional financial interests.